EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹1,044 Cr | ₹817 Cr | ₹459 Cr | ₹309 Cr | ₹-217 Cr |
What is the latest Net Current Assets ratio of EMCURE PHARMACEUTICALS ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹1,044 Cr |
Mar2023 | ₹817 Cr |
Mar2022 | ₹459 Cr |
Mar2021 | ₹309 Cr |
Mar2020 | ₹-217 Cr |
How is Net Current Assets of EMCURE PHARMACEUTICALS Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹1,044 Cr | 27.83 | |
Mar2023 | ₹817 Cr | 77.83 | |
Mar2022 | ₹459 Cr | 48.50 | |
Mar2021 | ₹309 Cr | Positive | |
Mar2020 | ₹-217 Cr | - |
Compare Net Current Assets of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹25,725.6 Cr | -0.3% | 3.4% | -0.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | -0.3% |
3.4% |
-0.1% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses